Literature DB >> 7543859

RAPD analysis of isolates of Burkholderia pseudomallei from patients with recurrent melioidosis.

A Haase1, A Melder, H Smith-Vaughan, D Kemp, B Currie.   

Abstract

Twenty-seven isolates of Burholderia pseudomallei (formerly Pseudomonas pseudomallei) from ten patients with recurrent melioidosis were analysed by RAPD. In two cases RAPD patterns in recurrent isolates differed from the original isolates; one was considered a likely reinfection while the other may represent relapse from one of two strains initially infecting the patient. In two cases where a change in antibiotic resistance had occurred between original and relapse isolates, slight changes in RAPD patterns were found with one of the four primers used. In the other six cases the relapse was clearly due to the original strain re-emerging unchanged, with identical RAPD patterns with all four primers.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7543859      PMCID： PMC2271559          DOI： 10.1017/s0950268800058179

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


  19 in total

1.  Melioidosis: a reminder.

Authors:  R E Morrison; A S Lamb; D B Craig; W M Johnson
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

2.  Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure.

Authors:  E E Mays; E A Ricketts
Journal:  Chest       Date:  1975-08       Impact factor: 9.410

3.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Authors:  J G Williams; A R Kubelik; K J Livak; J A Rafalski; S V Tingey
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

4.  Fingerprinting genomes using PCR with arbitrary primers.

Authors:  J Welsh; M McClelland
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

5.  Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand.

Authors:  W Chaowagul; N J White; D A Dance; Y Wattanagoon; P Naigowit; T M Davis; S Looareesuwan; N Pitakwatchara
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

Review 6.  Melioidosis: review and update.

Authors:  A Leelarasamee; S Bovornkitti
Journal:  Rev Infect Dis       Date:  1989 May-Jun

7.  DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting.

Authors:  N Akopyanz; N O Bukanov; T U Westblom; S Kresovich; D E Berg
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

8.  Septic melioidosis after a visit to Southeast Asia.

Authors:  J J Bouvy; J E Degener; C Stijnen; M P Gallee; B van der Berg
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

9.  Diversity among clinical isolates of Histoplasma capsulatum detected by polymerase chain reaction with arbitrary primers.

Authors:  D Kersulyte; J P Woods; E J Keath; W E Goldman; D E Berg
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

10.  Melioidosis in the Northern Territory of Australia.

Authors:  J W Rode; D D Webling
Journal:  Med J Aust       Date:  1981-02-21       Impact factor: 7.738
View more
  12 in total

1.  Brief communication genotyping of Burkholderia pseudomallei revealed high genetic variability among isolates from a single population group.

Authors:  Abdelrahman Mohammad Zueter; Zaidah Abdul Rahman; Chan Yean Yean; Azian Harun
Journal:  Int J Mol Epidemiol Genet       Date:  2015-09-09

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  The epidemiology of melioidosis in the Balimo region of Papua New Guinea.

Authors:  J M Warner; D B Pelowa; D Gal; G Rai; M Mayo; B J Currie; B Govan; L F Skerratt; R G Hirst
Journal:  Epidemiol Infect       Date:  2007-08-22       Impact factor: 2.451

4.  Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.

Authors:  I-Ching Sam; Kah Heng See; Savithri D Puthucheary
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

5.  Melioidosis: an emerging infection in Taiwan?

Authors:  P R Hsueh; L J Teng; L N Lee; C J Yu; P C Yang; S W Ho; K T Luh
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

6.  CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice.

Authors:  Yao-Shen Chen; Yu-Shan Hsiao; Hsi-Hsun Lin; Yin Liu; Ya-Lei Chen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

7.  Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare.

Authors:  Derek S Sarovich; Linda Ward; Erin P Price; Mark Mayo; Matthew C Pitman; Robert W Baird; Bart J Currie
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

8.  Strategies for Intracellular Survival of Burkholderia pseudomallei.

Authors:  Elizabeth M Allwood; Rodney J Devenish; Mark Prescott; Ben Adler; John D Boyce
Journal:  Front Microbiol       Date:  2011-08-22       Impact factor: 5.640

9.  Identification of circulating bacterial antigens by in vivo microbial antigen discovery.

Authors:  Dana E Nuti; Reva B Crump; Farida Dwi Handayani; Narisara Chantratita; Sharon J Peacock; Richard Bowen; Philip L Felgner; D Huw Davies; Terry Wu; C Rick Lyons; Paul J Brett; Mary N Burtnick; Thomas R Kozel; David P AuCoin
Journal:  mBio       Date:  2011-08-16       Impact factor: 7.867

10.  Evolution of Burkholderia pseudomallei in recurrent melioidosis.

Authors:  Hillary S Hayden; Regina Lim; Mitchell J Brittnacher; Elizabeth H Sims; Elizabeth R Ramage; Christine Fong; Zaining Wu; Eva Crist; Jean Chang; Yang Zhou; Matthew Radey; Laurence Rohmer; Eric Haugen; Will Gillett; Vanaporn Wuthiekanun; Sharon J Peacock; Rajinder Kaul; Samuel I Miller; Colin Manoil; Michael A Jacobs
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.